Phenylalanine and Its Impact on Cognition
Clinical trial NCT03788343 · COMPLETED
Trial details
- NCT number
- NCT03788343
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-19
- Primary completion
- 2022-06-17
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.